U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar: April 19-25, 2020
  1. FDA Meetings, Conferences and Workshops

Public Calendar: April 19-25, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 04/20/2020
Location: Teleconference
Subject: Quarterly PDUFA VI Leadership Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from industry

Event Date: 04/24/2020
Location: Teleconference
Subject: Hever COVID-19 Research Connectivity
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from government, industry, and other invited guests

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 04/20/2020
Location: Virtual
Subject: Duke-Margolis / Alexandria Summit Webinar: Developing a Therapeutic Response to COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Patients, academia, industry, government, and other stakeholders

Event Date: 04/23/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, providers, industry, academia, government, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 04/23/2020
Location: Virtual Meeting
Subject: American Society of Clinical Oncology (ASCO); COVID-19 and Cancer: A Healthcare System in Crisis
FDA Participant/Group: N/A
Non FDA Participant/Group: Dr. Gary Lyman (Hutchinson Institute for Cancer Outcomes Research); Richard L. Schilsky (ASCO); Melissa Dillmon (Harbin Clinic Cancer Center ); Jonathan Marron (Dana-Farber/Boston Children's Cancer and Blood Disorders Center); Howard A. Burris (Sarah Cannon Research Institute );

Event Date: 04/23/2020
Location: Teleconference
Subject: University of Arizona Partnership with State to Provide COVID-19 Antibody Tests
FDA Participant/Group: STEVEN GITTERMAN; BRENDAN O'LEARY;
Non FDA Participant/Group: Cara Christ, Jessica Rigler, Kenneth Komastu, Shane Brady, Victor Waddell, Wendy Snyder (Arizona Dept of Health Services);

Event Date: 04/24/2020
Location: Teleconference
Subject: COVID-19 Vaccine Development and Testing Town Hall; Hosted by Rep Ralph Norman (R-SC)
FDA Participant/Group: N/A
Non FDA Participant/Group: Michael Kacka (South Carolina Dept of Health and Environmental Control (SC-DHEC) ); Arash Poursina (Infectious Disease Specialists of Piedmont );

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 04/20/2020
Location: Virtual Meeting
Subject: Food Supply Chain Issues in Response to COVID-19
FDA Participant/Group: CAITLIN BOON; NINA ZIMDAHL; ANDREW KENNEDY;
Non FDA Participant/Group: Claudia Davidson, Conner Jager, Julie Bush, Liz Stone (Palantir Technologies );

Event Date: 04/20/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: Several officials from FDA, CDC, and HHS
Non FDA Participant/Group: Several representatives from the food and beverage industry

Event Date: 04/24/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: Several officials from FDA, CDC, and HHS
Non FDA Participant/Group: Several representatives from the produce industry

Event Date: 04/24/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: DAVID GOLDMAN; ROSEMARY EARLEY; DANIEL HATTIS; LEEANNE JACKSON;
Non FDA Participant/Group: Christian Lovell (Rep. Rosa DeLauro [D-CT]);

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event